Estrella Immunopharma (ESLA) Analyst & Key Data

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

1

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$0.66

DCF Value-96.40%

$0.02

Potential downside vs current price

Current Stock Price

$0.66

DCF Value-96.40%

$0.02

Potential downside vs current price

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

1

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$0.66

DCF Value-96.40%

$0.02

Potential downside vs current price

Current Stock Price

$0.66

DCF Value-96.40%

$0.02

Potential downside vs current price

Estrella Immunopharma, Inc.